Alnylam Pharmaceuticals Aktie
275,70
EUR
+1,20
EUR
+0,44
%
318,00
USD
-10,39
USD
-3,16
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung